CTAP manufacturers
- CTAP
-
- $1.00 / 1g
-
2020-03-06
- CAS:103429-32-9
- Min. Order: 1g
- Purity: ≥98%
- Supply Ability: g/kg/Ton
|
storage temp. | -20°C | form | Solid | Water Solubility | Soluble to 1 mg/ml in water |
Uses | CTAP acts as a selective μ-opioid receptor antagonist with a multitude of applications including the regulation of aggressive behavior in mammals. Activation of μ-opioid receptors in the central nucleus of the amygdala, is responsible for mechanisms related to the control of sodium appetite and regulation of sodium intake. | Uses | CTAP has been used as a μ-opioid receptor (MOR) antagonist:
- to study the anti-hyperalgesic effect of dipeptidyl peptidase 4 (DPP4) inhibitor isoleucine-proline-isoleucine (IPI) and vildagliptin in carrageenan-induced inflammation
- to study the role of MOR in glutamate and gamma-aminobutyric acid (GABA) efflux during predator stress in rats
- to determine the endogenous opioid peptide involved in blocking pain induced by activated gastrin-releasing peptide (Grp+) neurons
| Biochem/physiol Actions | CTAP is a peptide antagonist produced from somatostatin analogs. | storage | Store at -20°C |
| CTAP Preparation Products And Raw materials |
|